Molecular Cancer Therapeutics· @MCT_AACR · X·· 2026-04-21Score60
Body · original
Online now! Simultaneous publication with an #AACR26 poster: #FirstDisclosure of ABL209 (NEOK002), an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic window
https://
aacrjournals.org/mct/article/do
i/10.1158/1535-7163.MCT-26-0088
…
Heat 0 · 0 likes · 0 replies · 0 reposts
Conference abstracts
1726matched by 代号 NEOK002
NEOK002 (ABL209): Redesigning an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic windowBora Lee, Hyeon Ji Park, Byeong Min Yoo, Hangil Kim, Junyoung Kim, Arim Seo, Youngeun Hong, Donghoon Yeom, Yong-Gyu Son, Jaehyun Eom, Byungje Sung, Jinhyung Ahn, Jinwon Jung, Weon-Kyoo You, Sang Hoon Lee
Read the abstract →Source: Molecular Cancer Therapeutics · x.com